nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—pancreatic cancer	0.671	1	CbGaD
Ketorolac—Tolmetin—CXCL8—pancreatic cancer	0.00193	0.282	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—pancreatic cancer	0.000943	0.137	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—pancreatic cancer	0.000714	0.104	CrCbGaD
Ketorolac—Nepafenac—PTGS2—pancreatic cancer	0.000679	0.0989	CrCbGaD
Ketorolac—Fenbufen—PTGS2—pancreatic cancer	0.000649	0.0946	CrCbGaD
Ketorolac—Tolmetin—PTGS2—pancreatic cancer	0.000564	0.0822	CrCbGaD
Ketorolac—Salsalate—PTGS2—pancreatic cancer	0.000564	0.0822	CrCbGaD
Ketorolac—Suprofen—PTGS2—pancreatic cancer	0.000541	0.0788	CrCbGaD
Ketorolac—Ketoprofen—PTGS2—pancreatic cancer	0.000275	0.0401	CrCbGaD
Ketorolac—Asthenia—Gemcitabine—pancreatic cancer	0.000133	0.000412	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—pancreatic cancer	0.000132	0.000411	CcSEcCtD
Ketorolac—Confusional state—Docetaxel—pancreatic cancer	0.000132	0.000411	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000132	0.000408	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000131	0.000407	CcSEcCtD
Ketorolac—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000131	0.000407	CcSEcCtD
Ketorolac—Oedema—Docetaxel—pancreatic cancer	0.000131	0.000407	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—pancreatic cancer	0.000131	0.000407	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—pancreatic cancer	0.000131	0.000406	CcSEcCtD
Ketorolac—Pruritus—Gemcitabine—pancreatic cancer	0.000131	0.000406	CcSEcCtD
Ketorolac—Infection—Docetaxel—pancreatic cancer	0.00013	0.000404	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00013	0.000403	CcSEcCtD
Ketorolac—Diarrhoea—Irinotecan—pancreatic cancer	0.00013	0.000403	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—pancreatic cancer	0.00013	0.000402	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—pancreatic cancer	0.000129	0.000401	CcSEcCtD
Ketorolac—Shock—Docetaxel—pancreatic cancer	0.000129	0.000401	CcSEcCtD
Ketorolac—Nervous system disorder—Docetaxel—pancreatic cancer	0.000129	0.000399	CcSEcCtD
Ketorolac—Pruritus—Fluorouracil—pancreatic cancer	0.000129	0.000399	CcSEcCtD
Ketorolac—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000129	0.000399	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—pancreatic cancer	0.000128	0.000398	CcSEcCtD
Ketorolac—Tachycardia—Docetaxel—pancreatic cancer	0.000128	0.000397	CcSEcCtD
Ketorolac—Skin disorder—Docetaxel—pancreatic cancer	0.000128	0.000395	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000127	0.000395	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—pancreatic cancer	0.000127	0.000393	CcSEcCtD
Ketorolac—Diarrhoea—Gemcitabine—pancreatic cancer	0.000127	0.000393	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—pancreatic cancer	0.000126	0.000392	CcSEcCtD
Ketorolac—Dizziness—Irinotecan—pancreatic cancer	0.000126	0.000389	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—pancreatic cancer	0.000125	0.000388	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—pancreatic cancer	0.000125	0.000388	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—pancreatic cancer	0.000125	0.000388	CcSEcCtD
Ketorolac—Anorexia—Docetaxel—pancreatic cancer	0.000125	0.000388	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—pancreatic cancer	0.000125	0.000388	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000125	0.000387	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—pancreatic cancer	0.000125	0.000387	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—pancreatic cancer	0.000125	0.000387	CcSEcCtD
Ketorolac—Diarrhoea—Fluorouracil—pancreatic cancer	0.000124	0.000386	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—pancreatic cancer	0.000123	0.000382	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000123	0.000382	CcSEcCtD
Ketorolac—Hypotension—Docetaxel—pancreatic cancer	0.000123	0.00038	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—pancreatic cancer	0.000122	0.00038	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000122	0.00038	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—pancreatic cancer	0.000122	0.000379	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000121	0.000377	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—pancreatic cancer	0.000121	0.000376	CcSEcCtD
Ketorolac—Vomiting—Irinotecan—pancreatic cancer	0.000121	0.000374	CcSEcCtD
Ketorolac—Dizziness—Fluorouracil—pancreatic cancer	0.00012	0.000373	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—pancreatic cancer	0.00012	0.000372	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00012	0.000372	CcSEcCtD
Ketorolac—Rash—Irinotecan—pancreatic cancer	0.00012	0.000371	CcSEcCtD
Ketorolac—Dermatitis—Irinotecan—pancreatic cancer	0.00012	0.000371	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00012	0.000371	CcSEcCtD
Ketorolac—Headache—Irinotecan—pancreatic cancer	0.000119	0.000369	CcSEcCtD
Ketorolac—Insomnia—Docetaxel—pancreatic cancer	0.000119	0.000368	CcSEcCtD
Ketorolac—Paraesthesia—Docetaxel—pancreatic cancer	0.000118	0.000366	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—pancreatic cancer	0.000118	0.000365	CcSEcCtD
Ketorolac—Vomiting—Gemcitabine—pancreatic cancer	0.000118	0.000365	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—pancreatic cancer	0.000117	0.000364	CcSEcCtD
Ketorolac—Dyspnoea—Docetaxel—pancreatic cancer	0.000117	0.000363	CcSEcCtD
Ketorolac—Somnolence—Docetaxel—pancreatic cancer	0.000117	0.000362	CcSEcCtD
Ketorolac—Rash—Gemcitabine—pancreatic cancer	0.000117	0.000362	CcSEcCtD
Ketorolac—Dermatitis—Gemcitabine—pancreatic cancer	0.000117	0.000361	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—pancreatic cancer	0.000116	0.000361	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—pancreatic cancer	0.000116	0.00036	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Headache—Gemcitabine—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Flushing—Epirubicin—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Vomiting—Fluorouracil—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—pancreatic cancer	0.000116	0.000359	CcSEcCtD
Ketorolac—Dyspepsia—Docetaxel—pancreatic cancer	0.000116	0.000358	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—pancreatic cancer	0.000115	0.000358	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—pancreatic cancer	0.000115	0.000358	CcSEcCtD
Ketorolac—Rash—Fluorouracil—pancreatic cancer	0.000115	0.000356	CcSEcCtD
Ketorolac—Dermatitis—Fluorouracil—pancreatic cancer	0.000115	0.000355	CcSEcCtD
Ketorolac—Decreased appetite—Docetaxel—pancreatic cancer	0.000114	0.000354	CcSEcCtD
Ketorolac—Headache—Fluorouracil—pancreatic cancer	0.000114	0.000353	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000114	0.000353	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000113	0.000351	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000113	0.000351	CcSEcCtD
Ketorolac—Fatigue—Docetaxel—pancreatic cancer	0.000113	0.000351	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—pancreatic cancer	0.000113	0.000351	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—pancreatic cancer	0.000113	0.000351	CcSEcCtD
Ketorolac—Nausea—Irinotecan—pancreatic cancer	0.000113	0.00035	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—pancreatic cancer	0.000113	0.000349	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000112	0.000348	CcSEcCtD
Ketorolac—Pain—Docetaxel—pancreatic cancer	0.000112	0.000348	CcSEcCtD
Ketorolac—Constipation—Docetaxel—pancreatic cancer	0.000112	0.000348	CcSEcCtD
Ketorolac—Chills—Epirubicin—pancreatic cancer	0.000112	0.000347	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—pancreatic cancer	0.000111	0.000345	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—pancreatic cancer	0.000111	0.000345	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—pancreatic cancer	0.00011	0.000342	CcSEcCtD
Ketorolac—Nausea—Gemcitabine—pancreatic cancer	0.00011	0.000341	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—pancreatic cancer	0.000109	0.000339	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000109	0.000338	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—pancreatic cancer	0.000108	0.000336	CcSEcCtD
Ketorolac—Erythema—Epirubicin—pancreatic cancer	0.000108	0.000336	CcSEcCtD
Ketorolac—Feeling abnormal—Docetaxel—pancreatic cancer	0.000108	0.000335	CcSEcCtD
Ketorolac—Nausea—Fluorouracil—pancreatic cancer	0.000108	0.000335	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—pancreatic cancer	0.000108	0.000334	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—pancreatic cancer	0.000108	0.000333	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000107	0.000333	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000107	0.000332	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—pancreatic cancer	0.000107	0.000332	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—pancreatic cancer	0.000107	0.000332	CcSEcCtD
Ketorolac—Tension—Epirubicin—pancreatic cancer	0.000106	0.00033	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—pancreatic cancer	0.000106	0.000329	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—pancreatic cancer	0.000105	0.000327	CcSEcCtD
Ketorolac—Back pain—Epirubicin—pancreatic cancer	0.000105	0.000325	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—pancreatic cancer	0.000105	0.000324	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—pancreatic cancer	0.000104	0.000323	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000104	0.000322	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—pancreatic cancer	0.000104	0.000322	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—pancreatic cancer	0.000104	0.000322	CcSEcCtD
Ketorolac—Chills—Doxorubicin—pancreatic cancer	0.000103	0.000321	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—pancreatic cancer	0.000103	0.000319	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—pancreatic cancer	0.000102	0.000317	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—pancreatic cancer	0.000102	0.000316	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—pancreatic cancer	0.000101	0.000313	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000101	0.000312	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—pancreatic cancer	0.0001	0.000311	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—pancreatic cancer	0.0001	0.000311	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—pancreatic cancer	0.0001	0.000311	CcSEcCtD
Ketorolac—Agitation—Epirubicin—pancreatic cancer	9.97e-05	0.000309	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—pancreatic cancer	9.89e-05	0.000307	CcSEcCtD
Ketorolac—Tension—Doxorubicin—pancreatic cancer	9.85e-05	0.000306	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—pancreatic cancer	9.83e-05	0.000305	CcSEcCtD
Ketorolac—Malaise—Epirubicin—pancreatic cancer	9.78e-05	0.000303	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—pancreatic cancer	9.75e-05	0.000302	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—pancreatic cancer	9.75e-05	0.000302	CcSEcCtD
Ketorolac—Syncope—Epirubicin—pancreatic cancer	9.73e-05	0.000302	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—pancreatic cancer	9.71e-05	0.000301	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—pancreatic cancer	9.71e-05	0.000301	CcSEcCtD
Ketorolac—Hypersensitivity—Docetaxel—pancreatic cancer	9.67e-05	0.0003	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—pancreatic cancer	9.59e-05	0.000297	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—pancreatic cancer	9.54e-05	0.000296	CcSEcCtD
Ketorolac—Cough—Epirubicin—pancreatic cancer	9.47e-05	0.000294	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—pancreatic cancer	9.46e-05	0.000293	CcSEcCtD
Ketorolac—Asthenia—Docetaxel—pancreatic cancer	9.42e-05	0.000292	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—pancreatic cancer	9.4e-05	0.000292	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—pancreatic cancer	9.37e-05	0.00029	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.31e-05	0.000289	CcSEcCtD
Ketorolac—Pruritus—Docetaxel—pancreatic cancer	9.29e-05	0.000288	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—pancreatic cancer	9.28e-05	0.000288	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—pancreatic cancer	9.24e-05	0.000286	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—pancreatic cancer	9.24e-05	0.000286	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—pancreatic cancer	9.24e-05	0.000286	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—pancreatic cancer	9.23e-05	0.000286	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—pancreatic cancer	9.21e-05	0.000285	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.17e-05	0.000284	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—pancreatic cancer	9.13e-05	0.000283	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—pancreatic cancer	9.05e-05	0.000281	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—pancreatic cancer	9.03e-05	0.00028	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—pancreatic cancer	9.02e-05	0.00028	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—pancreatic cancer	9e-05	0.000279	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—pancreatic cancer	8.99e-05	0.000279	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—pancreatic cancer	8.98e-05	0.000279	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—pancreatic cancer	8.93e-05	0.000277	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—pancreatic cancer	8.87e-05	0.000275	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—pancreatic cancer	8.85e-05	0.000275	CcSEcCtD
Ketorolac—Oedema—Epirubicin—pancreatic cancer	8.85e-05	0.000275	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—pancreatic cancer	8.82e-05	0.000274	CcSEcCtD
Ketorolac—Infection—Epirubicin—pancreatic cancer	8.8e-05	0.000273	CcSEcCtD
Ketorolac—Cough—Doxorubicin—pancreatic cancer	8.76e-05	0.000272	CcSEcCtD
Ketorolac—Shock—Epirubicin—pancreatic cancer	8.71e-05	0.00027	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—pancreatic cancer	8.7e-05	0.00027	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—pancreatic cancer	8.68e-05	0.000269	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—pancreatic cancer	8.68e-05	0.000269	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—pancreatic cancer	8.67e-05	0.000269	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—pancreatic cancer	8.67e-05	0.000269	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—pancreatic cancer	8.64e-05	0.000268	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—pancreatic cancer	8.6e-05	0.000267	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—pancreatic cancer	8.56e-05	0.000265	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—pancreatic cancer	8.55e-05	0.000265	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—pancreatic cancer	8.55e-05	0.000265	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—pancreatic cancer	8.55e-05	0.000265	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—pancreatic cancer	8.52e-05	0.000264	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.49e-05	0.000263	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—pancreatic cancer	8.44e-05	0.000262	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—pancreatic cancer	8.44e-05	0.000262	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—pancreatic cancer	8.36e-05	0.000259	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—pancreatic cancer	8.35e-05	0.000259	CcSEcCtD
Ketorolac—Rash—Docetaxel—pancreatic cancer	8.28e-05	0.000257	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—pancreatic cancer	8.27e-05	0.000257	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—pancreatic cancer	8.27e-05	0.000256	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—pancreatic cancer	8.26e-05	0.000256	CcSEcCtD
Ketorolac—Headache—Docetaxel—pancreatic cancer	8.22e-05	0.000255	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—pancreatic cancer	8.19e-05	0.000254	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.19e-05	0.000254	CcSEcCtD
Ketorolac—Infection—Doxorubicin—pancreatic cancer	8.14e-05	0.000252	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.07e-05	0.00025	CcSEcCtD
Ketorolac—Shock—Doxorubicin—pancreatic cancer	8.06e-05	0.00025	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—pancreatic cancer	8.03e-05	0.000249	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.02e-05	0.000249	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—pancreatic cancer	8.01e-05	0.000248	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—pancreatic cancer	8e-05	0.000248	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—pancreatic cancer	7.96e-05	0.000247	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—pancreatic cancer	7.95e-05	0.000247	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.92e-05	0.000246	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—pancreatic cancer	7.89e-05	0.000245	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—pancreatic cancer	7.87e-05	0.000244	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—pancreatic cancer	7.81e-05	0.000242	CcSEcCtD
Ketorolac—Nausea—Docetaxel—pancreatic cancer	7.8e-05	0.000242	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—pancreatic cancer	7.79e-05	0.000242	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—pancreatic cancer	7.7e-05	0.000239	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—pancreatic cancer	7.66e-05	0.000237	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.64e-05	0.000237	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—pancreatic cancer	7.63e-05	0.000237	CcSEcCtD
Ketorolac—Pain—Epirubicin—pancreatic cancer	7.57e-05	0.000235	CcSEcCtD
Ketorolac—Constipation—Epirubicin—pancreatic cancer	7.57e-05	0.000235	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.46e-05	0.000231	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—pancreatic cancer	7.41e-05	0.00023	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—pancreatic cancer	7.36e-05	0.000228	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—pancreatic cancer	7.3e-05	0.000227	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—pancreatic cancer	7.3e-05	0.000226	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—pancreatic cancer	7.28e-05	0.000226	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.24e-05	0.000225	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—pancreatic cancer	7.21e-05	0.000224	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—pancreatic cancer	7.12e-05	0.000221	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.07e-05	0.000219	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—pancreatic cancer	7.06e-05	0.000219	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—pancreatic cancer	7.03e-05	0.000218	CcSEcCtD
Ketorolac—Pain—Doxorubicin—pancreatic cancer	7.01e-05	0.000217	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—pancreatic cancer	7.01e-05	0.000217	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—pancreatic cancer	7e-05	0.000217	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—pancreatic cancer	7e-05	0.000217	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—pancreatic cancer	6.75e-05	0.000209	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.7e-05	0.000208	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—pancreatic cancer	6.52e-05	0.000202	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—pancreatic cancer	6.51e-05	0.000202	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—pancreatic cancer	6.48e-05	0.000201	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—pancreatic cancer	6.48e-05	0.000201	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—pancreatic cancer	6.35e-05	0.000197	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—pancreatic cancer	6.26e-05	0.000194	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—pancreatic cancer	6.06e-05	0.000188	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—pancreatic cancer	6.04e-05	0.000187	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—pancreatic cancer	5.88e-05	0.000182	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—pancreatic cancer	5.86e-05	0.000182	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—pancreatic cancer	5.8e-05	0.00018	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—pancreatic cancer	5.63e-05	0.000175	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—pancreatic cancer	5.61e-05	0.000174	CcSEcCtD
Ketorolac—Rash—Epirubicin—pancreatic cancer	5.58e-05	0.000173	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—pancreatic cancer	5.58e-05	0.000173	CcSEcCtD
Ketorolac—Headache—Epirubicin—pancreatic cancer	5.55e-05	0.000172	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—pancreatic cancer	5.42e-05	0.000168	CcSEcCtD
Ketorolac—Nausea—Epirubicin—pancreatic cancer	5.26e-05	0.000163	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—pancreatic cancer	5.21e-05	0.000162	CcSEcCtD
Ketorolac—Rash—Doxorubicin—pancreatic cancer	5.17e-05	0.00016	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—pancreatic cancer	5.16e-05	0.00016	CcSEcCtD
Ketorolac—Headache—Doxorubicin—pancreatic cancer	5.13e-05	0.000159	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—pancreatic cancer	4.87e-05	0.000151	CcSEcCtD
